Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LEXX | US
-0.04
-1.39%
Healthcare
Biotechnology
31/05/2024
17/10/2024
2.83
2.90
3.05
2.79
Lexaria Bioscience Corp. operates as a biotechnology company. The company develops and out-licenses its DehydraTECH combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules encompassing fat-soluble vitamins pain medications hormones PDE5 inhibitors antivirals oral nicotine and its analogs and various cannabinoids. The company's DehydraTECH technology evaluates for a variety of therapeutic indications including hypertension heart disease dementia and diabetes. It is suitable for a variety of product formats such as pharmaceuticals nutraceuticals over the counter and consumer packaged goods. Lexaria Bioscience Corp. was incorporated in 2004 and is based in Kelowna Canada.
View LessLow Debt to Equity (< 0.25)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
40.7%1 month
45.0%3 months
81.6%6 months
91.2%-
-
4.78
0.01
0.01
-7.22
97.36
-
-4.53M
44.74M
44.74M
-
-2.07K
-
8.10
-70.66
1.80
2.05
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.62
Range1M
0.65
Range3M
1.77
Rel. volume
1.86
Price X volume
534.86K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CollPlant Holdings Ltd | CLGN | Biotechnology | 4.28 | 49.03M | -5.10% | n/a | 0.00% |
Rafael Holdings Inc | RFL | Biotechnology | 1.97 | 48.40M | -3.90% | n/a | 2.77% |
Anebulo Pharmaceuticals Inc. Common Stock | ANEB | Biotechnology | 1.83 | 47.46M | -3.17% | n/a | 0.00% |
Immix Biopharma Inc. | IMMX | Biotechnology | 1.69 | 46.39M | 17.36% | n/a | 4.57% |
Rallybio Corporation Common Stock | RLYB | Biotechnology | 1.09 | 45.22M | -0.46% | n/a | 0.35% |
Eyenovia Inc | EYEN | Biotechnology | 0.508 | 43.49M | -7.64% | n/a | -662.22% |
LAVA Therapeutics BV | LVTX | Biotechnology | 1.65 | 43.39M | 0.00% | n/a | 14.37% |
CALC | CALC | Biotechnology | 3.9595 | 42.57M | -4.36% | n/a | 0.00% |
Clene Nanomedicine Inc | CLNN | Biotechnology | 5.34 | 42.52M | -5.82% | n/a | -6472.02% |
Reviva Pharmaceuticals Holdings Inc. | RVPH | Biotechnology | 1.28 | 42.36M | 4.07% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.6 | 19.19M | 0.80% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 0.98 | 17.70M | -3.92% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5763 | 8.36M | -11.91% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2111 | 3.79M | 2.93% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.04 | 2.71M | -4.59% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0114 | 1.02M | 14.00% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.16 | 0 | -0.43% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.3 | 0 | 2.14% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.535 | 0 | 7.00% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.07 | 0 | 1.90% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.22 | 0.53 | Cheaper |
Ent. to Revenue | 97.36 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 4.78 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 81.55 | 72.92 | Par |
Debt to Equity | 0.01 | -1.24 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 44.74M | 3.78B | Emerging |